Stay updated on Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial

Sign up to get notified when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for a phase 2 neoadjuvant HER2-positive breast cancer study is now displayed, with study design, participant criteria, locations, outcomes, and a protocol document. The record indicates that the study is active but not recruiting.
    Difference
    70%
    Check dated 2026-11-10T20:36:41.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T21:22:00.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology during the website transition appears above the 403 error page. The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:01:20.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:45:55.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error with a simple header and a Home link, indicating the page is inaccessible rather than containing updated study details.
    Difference
    21%
    Check dated 2026-09-22T23:40:59.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.6 to v3.7.0, indicating a newer version of the record; this is metadata about the page rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-09-15T23:47:01.000Z thumbnail image

Stay in the know with updates to Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.